Daniel J. Aires MD, JD, FAAD

Daniel Aires, MD is a board-certified dermatologist with over 15 years of experience treating a broad variety of dermatologic conditions. He has special interest in skin cancer diagnosis and treatment, general dermatology, and cutaneous T-cell lymphoma.

He earned his undergraduate degree and juris doctorate from Harvard College and Harvard Law School. He then went on to earn his medical doctorate at Yale School of Medicine. With a newfound passion for dermatology, Dr. Aires then completed an internship at Brigham and Women’s Hospital, his dermatology residency at the University of Texas Southwestern, and a fellowship at the Harvard Skin Disease Research Center.

In addition to his education, Dr. Aires has been involved in educating future dermatologists, authored textbook chapters and over 100 publications. He has served on the faculty at Harvard and as a professor and director of Dermatology at University of Kansas. He has been recognized by his peers as a Castle-Connolly Top Doctor and due to his unique education, has served an expert witness for medico-legal issues.

Outside of the office, Dr. Aires enjoys spending time with his family and watching his children compete in fencing and tennis. He also enjoys good music and food in his spare time.

Professional Associations:

• American Board of Dermatology – Board Certified
• American Academy of Dermatology – served on Advisory Board 2016-2019

Selected Publications:

• Lu et al. Formulation and preclinical evaluation of a toll-like receptor 7/8 agonist as an anti-tumoral immunomodulator. Control Release. 2019 Jul 28;306:165-176.
• Aires et al. T Cell Trafficking Plays a Role in Rapid Rejection of Allogeneic Tumors. Laboratory Investigation. 2019 Jan;99(1):85-92.
• Kelly et al. Vinegar Sock Soaks for Onychomycosis and/or Tinea Pedis. J Am Acad Dermatol. 2017 Sep 22.
• Rickstrew et al. Mitigation or prevention of early hair dye contact dermatitis via pre application of clobetasol foam. J Am Acad Dermatol. 2017 Nov;77(5):e129.
• Seremet et al. 75% Complete Response and 15% Partial Response to Extracorporeal Photopheresis Combined With Other Therapies in Resistant Early Stage Cutaneous T-Cell Lymphoma. J Drugs Dermatol. 2016 Oct 1;15(10):1212-1216.
• Aires et al. Polyphenol food supplementation extends life in intermittently fasted mice. Biochim Biophysica Acta – Molecular Basis of Disease 2012 Apr;1822(4):522-26.